These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22414960)

  • 21. Axonal regeneration inhibitors: emerging therapeutic options.
    Rosochowicz TW; Wrotek S; Kozak W
    Acta Neurol Belg; 2015 Dec; 115(4):527-32. PubMed ID: 25567550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nogo and the Nogo-66 receptor.
    Fournier AE; GrandPré T; Gould G; Wang X; Strittmatter SM
    Prog Brain Res; 2002; 137():361-9. PubMed ID: 12440378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unveiling the modulation of Nogo receptor in neuroregeneration and plasticity: Novel aspects and future horizon in a new frontier.
    Dave BP; Shah KC; Shah MB; Chorawala MR; Patel VN; Shah PA; Shah GB; Dhameliya TM
    Biochem Pharmacol; 2023 Apr; 210():115461. PubMed ID: 36828272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Nogo-A in axonal plasticity, regrowth and repair.
    Pernet V; Schwab ME
    Cell Tissue Res; 2012 Jul; 349(1):97-104. PubMed ID: 22588543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury.
    Yang J; Han Y; Ye W; Liu F; Zhuang K; Wu G
    J Surg Res; 2013 Jun; 182(2):e69-77. PubMed ID: 23207171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOGO-A induction and localization during chick brain development indicate a role disparate from neurite outgrowth inhibition.
    Caltharp SA; Pira CU; Mishima N; Youngdale EN; McNeill DS; Liwnicz BH; Oberg KC
    BMC Dev Biol; 2007 Apr; 7():32. PubMed ID: 17433109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter inhibitors in CNS axon regeneration failure.
    Xie F; Zheng B
    Exp Neurol; 2008 Feb; 209(2):302-12. PubMed ID: 17706966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NgR acts as an inhibitor to axonal regeneration in adults.
    Zhang S; Zhang Q; Zhang JH; Qin X
    Front Biosci; 2008 Jan; 13():2030-40. PubMed ID: 17981689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history of the myelin-derived nerve growth inhibitor Nogo-A.
    Schweigreiter R
    Neuron Glia Biol; 2008 May; 4(2):83-9. PubMed ID: 19737432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nogo-A represses anatomical and synaptic plasticity in the central nervous system.
    Kempf A; Schwab ME
    Physiology (Bethesda); 2013 May; 28(3):151-63. PubMed ID: 23636261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase B is involved in Nogo-66 inhibiting neurite outgrowth in PC12 cells.
    Wang H; Shen J; Xiong N; Zhao H; Chen Y
    Neuroreport; 2011 Oct; 22(15):733-8. PubMed ID: 21862940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
    Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
    Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research progress in neurite growth inhibitor Nogo].
    Lu SH; Liu SJ
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):241-4. PubMed ID: 14628472
    [No Abstract]   [Full Text] [Related]  

  • 34. Nogo in the injured spinal cord.
    Schweigreiter R; Bandtlow CE
    J Neurotrauma; 2006; 23(3-4):384-96. PubMed ID: 16629624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nogo in multiple sclerosis: growing roles of a growth inhibitor.
    Fontoura P; Steinman L
    J Neurol Sci; 2006 Jun; 245(1-2):201-10. PubMed ID: 16682057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nogo signaling and non-physical injury-induced nervous system pathology.
    Teng FY; Tang BL
    J Neurosci Res; 2005 Feb; 79(3):273-8. PubMed ID: 15619232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
    Liu BP; Fournier A; GrandPré T; Strittmatter SM
    Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
    Pot C; Simonen M; Weinmann O; Schnell L; Christ F; Stoeckle S; Berger P; Rülicke T; Suter U; Schwab ME
    J Cell Biol; 2002 Oct; 159(1):29-35. PubMed ID: 12379801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repulsive factors and axon regeneration in the CNS.
    Fournier AE; Strittmatter SM
    Curr Opin Neurobiol; 2001 Feb; 11(1):89-94. PubMed ID: 11179877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.